University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 12 of 23
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
NCT02796144
Shifts in the Oral Biofilm of Patients With Known Oral Health Risk Factors
NCT02885064
Accelerated Invisalign Therapy in Conjunction With Acceledent Aura
NCT02868554
Acute Concussion Therapy Intervention Training in Healthy and Concussed Participants
NCT02872480
A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction
NCT02844569
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
NCT02823600
VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health
NCT03079882
North Carolina Newborn Exome Sequencing for Universal Screening
NCT02826694
Does a Mainstream Summer Camp Experience Improve Pediatric Kidney Patients' Physical Fitness and Self Concept?
NCT02803541
A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
NCT02781818
Risk Factors for Microscopic Colitis
NCT02699333
Clinical Outcomes Maxilla: Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine
NCT02747186
Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology
NCT02872467
IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis
NCT02710903
Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)
NCT02722148
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects
NCT02641444
ARV Concentrations in Hair
NCT02768779
Microbiome-mediated Weight, Anxiety, and Stress Dysregulation in Anorexia Nervosa
NCT03119272
Conventional, Overdenture and Palateless Overdenture Oral Health Impact Comparison Study
NCT02731703
Pain Coping Skills Training for African Americans With Osteoarthritis
NCT02560922
Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials
NCT02532543
Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine
NCT02708433
Triggered Palliative Care for Advanced Dementia
NCT02719938
Walk With Ease Program For Patients With Systemic Lupus Erythematosus
NCT02631005
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
NCT02707900
Tick-borne Illness and Clothing Study of Rhode Island
NCT02613585
Testing the Efficacy of a Spousal Support Enhanced Weight Loss Program on Weight Loss Among African American Men
NCT02458053
Oxytocin Treatment of Opioid Dependence
NCT02548728
Contrast-enhanced Ultrasound of the Kidney
NCT02684435
Does Propranolol Attenuate Inflammatory Responses to a Psychological Stressor?
NCT02972554
Impact of an Oral Health Intervention
NCT03921632
Technology Enhanced Behavioral Activation Treatment for Substance Use
NCT02707887
To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma
NCT02662413
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
NCT02833714
The Compartmental Biology of HIV in the Male Genital Tract
NCT02638493
Clinical Outcomes of Buffered vs. Non-Buffered Lidocaine
NCT02620683
Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth
NCT02572570
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
NCT02527798
Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD
NCT02464059
Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects
NCT02610829
Self-Consent for PrEP Perspectives
NCT02801760
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS
NCT02104505
The Patient-Reported Outcomes Project of HCV-TARGET
NCT02601820
Vibratory Stimuli, A Novel Rehabilitation Method for Preventing Post - Traumatic Knee Osteoarthritis
NCT02605876
Perimenopausal Effects of Estradiol on Reward Responsiveness
NCT02255175
Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn
NCT02653157
The KNEEhabilitation Study: Improving Disability in Individuals With Knee Osteoarthritis
NCT02634814
The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services
NCT02398422
Methods for Managing Intrusive Thoughts
NCT03416504
Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study
NCT02220426
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.